Literature DB >> 23849831

Classification methods for the differentiation of atypical meningiomas using diffusion and perfusion techniques at 3-T MRI.

Patricia Svolos1, Evangelia Tsolaki, Kyriaki Theodorou, Konstantinos Fountas, Eftychia Kapsalaki, Ioannis Fezoulidis, Ioannis Tsougos.   

Abstract

The purpose was to investigate the contribution of machine learning algorithms using diffusion and perfusion techniques in the differentiation of atypical meningiomas from glioblastomas and metastases. Apparent diffusion coefficient, fractional anisotropy, and relative cerebral blood volume were measured in different tumor regions. Naive Bayes, k-Nearest Neighbor, and Support Vector Machine classifiers were used in the classification procedure. The application of classification methods adds incremental differential diagnostic value. Differentiation is mainly achieved using diffusion metrics, while perfusion measurements may provide significant information for the peritumoral regions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical meningioma; Classification algorithms; Diffusion/perfusion; High-grade gliomas; Metastasis

Mesh:

Year:  2013        PMID: 23849831     DOI: 10.1016/j.clinimag.2013.03.006

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  9 in total

Review 1.  Bayesian networks in neuroscience: a survey.

Authors:  Concha Bielza; Pedro Larrañaga
Journal:  Front Comput Neurosci       Date:  2014-10-16       Impact factor: 2.380

2.  Fast spectroscopic multiple analysis (FASMA) for brain tumor classification: a clinical decision support system utilizing multi-parametric 3T MR data.

Authors:  Evangelia Tsolaki; Patricia Svolos; Evanthia Kousi; Eftychia Kapsalaki; Ioannis Fezoulidis; Konstantinos Fountas; Kyriaki Theodorou; Constantine Kappas; Ioannis Tsougos
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-07-15       Impact factor: 2.924

3.  The diagnostic value of using combined MR diffusion tensor imaging parameters to differentiate between low- and high-grade meningioma.

Authors:  Kerim Aslan; Hediye Pinar Gunbey; Leman Tomak; Lutfi Incesu
Journal:  Br J Radiol       Date:  2018-05-31       Impact factor: 3.039

4.  The diagnostic value of texture analysis in predicting WHO grades of meningiomas based on ADC maps: an attempt using decision tree and decision forest.

Authors:  Yiping Lu; Li Liu; Shihai Luan; Ji Xiong; Daoying Geng; Bo Yin
Journal:  Eur Radiol       Date:  2018-08-07       Impact factor: 5.315

5.  Resting state fMRI feature-based cerebral glioma grading by support vector machine.

Authors:  Jiangfen Wu; Zhiyu Qian; Ling Tao; Jianhua Yin; Shangwen Ding; Yameng Zhang; Zhou Yu
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-09-17       Impact factor: 2.924

6.  Preoperative and postoperative prediction of long-term meningioma outcomes.

Authors:  Efstathios D Gennatas; Ashley Wu; Steve E Braunstein; Olivier Morin; William C Chen; Stephen T Magill; Chetna Gopinath; Javier E Villaneueva-Meyer; Arie Perry; Michael W McDermott; Timothy D Solberg; Gilmer Valdes; David R Raleigh
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

7.  Comparison of Canine and Feline Meningiomas Using the Apparent Diffusion Coefficient and Fractional Anisotropy.

Authors:  Masae Wada; Daisuke Hasegawa; Yuji Hamamoto; Yoshihiko Yu; Rikako Asada; Aki Fujiwara-Igarashi; Michio Fujita
Journal:  Front Vet Sci       Date:  2021-01-11

Review 8.  Use of advanced neuroimaging and artificial intelligence in meningiomas.

Authors:  Norbert Galldiks; Frank Angenstein; Jan-Michael Werner; Elena K Bauer; Robin Gutsche; Gereon R Fink; Karl-Josef Langen; Philipp Lohmann
Journal:  Brain Pathol       Date:  2022-03       Impact factor: 6.508

9.  The Diagnostic Value of Radiomics-Based Machine Learning in Predicting the Grade of Meningiomas Using Conventional Magnetic Resonance Imaging: A Preliminary Study.

Authors:  Chaoyue Chen; Xinyi Guo; Jian Wang; Wen Guo; Xuelei Ma; Jianguo Xu
Journal:  Front Oncol       Date:  2019-12-06       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.